Immunovant (IMVT) Operating Leases (2020 - 2024)
Immunovant (IMVT) posted Operating Leases of $138000.0 for Q1 2024, up 193.62% on a QoQ basis from $47000.0 in Q1 2023, and up 193.62% year-over-year from $47000.0 in Q2 2023.
Immunovant (IMVT) Operating Leases (2020 - 2024) Analysis & Trends
Immunovant's Operating Leases history runs 5 years deep, the most recent figure standing at $138000.0 for Q1 2024.
- Quarterly Operating Leases rose 193.62% year-over-year to $138000.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $138000.0 (up 193.62% YoY) and the FY2024 annual result came in at $138000.0, up 193.62% from the prior year.
- Operating Leases was $138000.0 for Q1 2024 at Immunovant, up from $47000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $4.2 million in Q2 2020 and bottomed at $47000.0 in Q1 2023.
- A 5-year average of $1.6 million and a median of $1.7 million in 2021 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2023 — Operating Leases slumped 96.14% — and 2024, when it jumped 193.62%.
- Immunovant's Operating Leases stood at $2.4 million in 2020, then declined by 29.77% to $1.7 million in 2021, then sank by 81.79% to $306000.0 in 2022, then tumbled by 84.64% to $47000.0 in 2023, then soared by 193.62% to $138000.0 in 2024.
- Business Quant data shows IMVT's Operating Leases at $138000.0 in Q1 2024, $47000.0 in Q1 2023, and $306000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Immunovant | 7.17 Bn | 7.17 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 138,000.00 |
| Mar 31, 2023 | 47,000.00 |
| Dec 31, 2022 | 306,000.00 |
| Sep 30, 2022 | 614,000.00 |
| Jun 30, 2022 | 919,000.00 |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 1.68 Mn |
| Sep 30, 2021 | 1.95 Mn |
| Jun 30, 2021 | 1.97 Mn |
| Mar 31, 2021 | 2.24 Mn |
| Dec 31, 2020 | 2.39 Mn |
| Sep 30, 2020 | 2.68 Mn |
| Jun 30, 2020 | 4.20 Mn |